A Comparison of the Effects of Extended Release Tacrolimus (Advagraf®) vs. Immediate Release Tacrolimus (Prograf®) on Kidney Function in Healthy Male Volunteers

Status:
Completed

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

The purpose of the study is to evaluate the drug profiles (pharmacokinetics) and effects (pharmacodynamics) of Advagraf® and Prograf® on the kidneys.

Phase 1

Astellas Pharma Canada, Inc.

Tacrolimus